Informationen:
Fehler:
ID
29214
Beschreibung
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs; ODM derived from: https://clinicaltrials.gov/show/NCT00537277
Link
https://clinicaltrials.gov/show/NCT00537277
Stichworte
Versionen (1)
- 08.03.18 08.03.18 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
8. März 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Diabetes NCT00537277
Eligibility Diabetes NCT00537277
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Diabetes NCT00537277
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
type 2 diabetes mellitus for more than 12 months
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0872146 (UMLS CUI [1,2])
Glucohemoglobin measurement
Item
hba1c: 7.5 - 11.0%
boolean
C0202054 (UMLS CUI [1])
Antidiabetics Stable
Item
an antidiabetic regimen that has been stable for at least 3 months prior to screening
boolean
C0935929 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,2])
Antidiabetics Oral Quantity | Evening Basal insulin | Bedtime Basal insulin
Item
an antidiabetic regimen that includes a minimum of 2 oral anti-diabetic drugs (oads) or 1 oad plus evening or bedtime basal insulin
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0587117 (UMLS CUI [2,1])
C0650607 (UMLS CUI [2,2])
C0521112 (UMLS CUI [3,1])
C0650607 (UMLS CUI [3,2])
C1527415 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0587117 (UMLS CUI [2,1])
C0650607 (UMLS CUI [2,2])
C0521112 (UMLS CUI [3,1])
C0650607 (UMLS CUI [3,2])
Antidiabetics Oral Dosage
Item
oads dosed at 50% or more of the maximum recommended dose
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C1527415 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
Insulin | Exception NPH insulin | Exception Insulin Glargine
Item
use of any insulin preparations other than nph or glargine within the past 6 months
boolean
C0021641 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0021658 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0907402 (UMLS CUI [3,2])
C1705847 (UMLS CUI [2,1])
C0021658 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0907402 (UMLS CUI [3,2])
Insulin U/day Quantity
Item
use of more than 60 units of insulin per day
boolean
C0021641 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0456683 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Administration of insulin Morning
Item
morning time insulin administration
boolean
C0199782 (UMLS CUI [1,1])
C0332170 (UMLS CUI [1,2])
C0332170 (UMLS CUI [1,2])
Insulin Dose Quantity per day
Item
use of more than one insulin dose daily
boolean
C0021641 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0439505 (UMLS CUI [1,4])
C0178602 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0439505 (UMLS CUI [1,4])